CD19: Difference between revisions
CSV import |
No edit summary Tag: Manual revert |
| (One intermediate revision by the same user not shown) | |
(No difference)
| |
Latest revision as of 17:15, 18 March 2025
CD19 is a type of protein that in humans is encoded by the CD19 gene. It is a member of the immunoglobulin superfamily and has two immunoglobulin (Ig) domains. The CD19 protein is expressed on the surface of B cells, a type of white blood cell.
Structure[edit]
The CD19 protein is a 95 kDa transmembrane glycoprotein that consists of 556 amino acids. It has a large extracellular domain that contains two Ig domains, and a small cytoplasmic domain that contains multiple phosphorylation sites.
Function[edit]
CD19 plays a crucial role in establishing intrinsic B cell signaling thresholds through modulating both B cell receptor (BCR)-dependent and independent signaling. It works in conjunction with CD21, CD81, and CD225 in the B cell co-receptor complex. The extracellular domain of CD19 interacts with the B cell receptor, while the cytoplasmic domain interacts with signaling molecules such as phosphatidylinositol 3-kinase (PI3K) and Lyn kinase.
Clinical significance[edit]
Alterations in CD19 expression levels or mutations in its gene have been implicated in various diseases. For instance, CD19 is often overexpressed in B cell lymphoma and leukemia, and is a target for various immunotherapies including CAR-T cell therapy. In contrast, CD19 deficiency is associated with hypogammaglobulinemia, a condition characterized by low levels of immunoglobulins and increased susceptibility to infections.
See also[edit]
References[edit]
<references />
